Human FAS/ALPS1A/APO-1 ORF/cDNA clone-Adenovirus plasmid (BC012479)
Cat. No.: pGMAP000450
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human FAS/ALPS1A/APO-1 adenoviral expression plasmid for FAS adenovirus packaging, FAS adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
Fas/CD95/FAS/FAS/ALPS1A products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAP000450 |
Gene Name | FAS |
Accession Number | BC012479 |
Gene ID | 355 |
Species | Human |
Product Type | Adenovirus plasmid (overexpression) |
Insert Length | 1008 bp |
Gene Alias | ALPS1A,APO-1,CD95,FASTM |
Fluorescent Reporter | GFP |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | EF1 |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGCTGGGCATCTGGACCCTCCTACCTCTGGTTCTTACGTCTGTTGCTAGATTATCGTCCAAAAGTGTTAATGCCCAAGTGACTGACATCAACTCCAAGGGATTGGAATTGAGGAAGACTGTTACTACAGTTGAGACTCAGAACTTGGAAGGCCTGCATCATGATGGCCAATTCTGCCATAAGCCCTGTCCTCCAGGTGAAAGGAAAGCTAGGGACTGCACAGTCAATGGGGATGAACCAGACTGCGTGCCCTGCCAAGAAGGGAAGGAGTACACAGACAAAGCCCATTTTTCTTCCAAATGCAGAAGATGTAGATTGTGTGATGAAGGACATGGCTTAGAAGTGGAAATAAACTGCACCCGGACCCAGAATACCAAGTGCAGATGTAAACCAAACTTTTTTTGTAACTCTACTGTATGTGAACACTGTGACCCTTGCACCAAATGTGAACATGGAATCATCAAGGAATGCACACTCACCAGCAACACCAAGTGCAAAGAGGAAGGATCCAGATCTAACTTGGGGTGGCTTTGTCTTCTTCTTTTGCCAATTCCACTAATTGTTTGGGTGAAGAGAAAGGAAGTACAGAAAACATGCAGAAAGCACAGAAAGGAAAACCAAGGTTCTCATGAATCTCCAACCTTAAATCCTGAAACAGTGGCAATAAATTTATCTGATGTTGACTTGAGTAAATATATCACCACTATTGCTGGAGTCATGACACTAAGTCAAGTTAAAGGCTTTGTTCGAAAGAATGGTGTCAATGAAGCCAAAATAGATGAGATCAAGAATGACAATGTCCAAGACACAGCAGAACAGAAAGTTCAACTGCTTCGTAATTGGCATCAACTTCATGGAAAGAAAGAAGCGTATGACACATTGATTAAAGATCTCAAAAAAGCCAATCTTTGTACTCTTGCAGAGAAAATTCAGACTATCATCCTCAAGGACATTACTAGTGACTCAGAAAATTCAAACTTCAGAAATGAAATCCAAAGCTTGGTCTAG |
ORF Protein Sequence | MLGIWTLLPLVLTSVARLSSKSVNAQVTDINSKGLELRKTVTTVETQNLEGLHHDGQFCHKPCPPGERKARDCTVNGDEPDCVPCQEGKEYTDKAHFSSKCRRCRLCDEGHGLEVEINCTRTQNTKCRCKPNFFCNSTVCEHCDPCTKCEHGIIKECTLTSNTKCKEEGSRSNLGWLCLLLLPIPLIVWVKRKEVQKTCRKHRKENQGSHESPTLNPETVAINLSDVDLSKYITTIAGVMTLSQVKGFVRKNGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQTIILKDITSDSENSNFRNEIQSLV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T14592-Ab | Anti-TNR6/ FAS/ ALPS1A monoclonal antibody |
Target Antigen | GM-Tg-g-T14592-Ag | FAS VLP (virus-like particle) |
ORF Viral Vector | pGMAP000450 | Human FAS Adenovirus plasmid |
ORF Viral Vector | vGMAP000450 | Human FAS Adenovirus particle |
Target information
Target ID | GM-T14592 |
Target Name | Fas/CD95/FAS |
Gene Group Identifier (Target Gene ID in Homo species) |
355 |
Gene ID |
100071639 (Equus caballus), 14102 (Mus musculus), 246097 (Rattus norvegicus), 282488 (Bos taurus) 355 (Homo sapiens), 486469 (Canis lupus familiaris), 493881 (Felis catus), 574332 (Macaca mulatta) |
Gene Symbols & Synonyms | FAS,Fas,lpr,APO1,APT1,CD95,TNFR6,Tnfrsf6,FasR,TNFRSF6,FAS1,APO-1,FASTM,ALPS1A |
Target Alternative Names | Fas, CD95, FAS,Tumor necrosis factor receptor superfamily member 6,Apo-1 antigen, Apoptosis-mediating surface antigen FAS, FASLG receptor,APT1,CD95,FAS1,APO-1,FASTM,ALPS1A,TNFRSF6 |
Uniprot Accession |
P25445,P25446,P51867,Q63199,Q9BDP2
Additional SwissProt Accessions: P25446,Q63199,P51867,P25445,Q9BDP2 |
Uniprot Entry Name | |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | cancer, Chronic Kidney Disease, Urinary bladder urothelial carcinoma, ovarian cancer |
Disease from KEGG | MAPK signaling pathway, Cytokine-cytokine receptor interaction, p53 signaling pathway, Apoptosis, Natural killer cell mediated cytotoxicity, TNF signaling pathway, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Pathogenic Escherichia coli infection, Chagas disease, African trypanosomiasis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Epstein-Barr virus infection, Pathways in cancer, Proteoglycans in cancer, Autoimmune thyroid disease, Allograft rejection, Graft-versus-host disease, Lipid and atherosclerosis |
Gene Ensembl | ENSECAG00000013724, ENSMUSG00000024778, ENSBTAG00000010785, ENSG00000026103, ENSCAFG00845029855, ENSMMUG00000009339 |
Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.